C
Chantal Ceuterick-de Groote
Researcher at University of Antwerp
Publications - 38
Citations - 2100
Chantal Ceuterick-de Groote is an academic researcher from University of Antwerp. The author has contributed to research in topics: Myopathy & Missense mutation. The author has an hindex of 19, co-authored 38 publications receiving 1881 citations. Previous affiliations of Chantal Ceuterick-de Groote include Elsevier.
Papers
More filters
Journal ArticleDOI
TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration
Hans Wils,Gernot Kleinberger,Jonathan Janssens,Sandra Pereson,Geert Joris,Ivy Cuijt,Veerle Smits,Chantal Ceuterick-de Groote,Christine Van Broeckhoven,Samir Kumar-Singh +9 more
TL;DR: A dose-dependent degeneration of cortical and spinal motor neurons and development of spastic quadriplegia reminiscent of ALS are shown and findings suggest that ≈25-kDa TDP-43 CTFs are noxious to neurons by a gain of aberrant nuclear function.
Journal ArticleDOI
Linezolid-Induced Inhibition of Mitochondrial Protein Synthesis
An S. De Vriese,Rudy Van Coster,Joël Smet,Sara Seneca,Andrew M. Lovering,Lindsey Van Haute,Ludo Vanopdenbosch,Jean-Jacques Martin,Chantal Ceuterick-de Groote,Stefaan J. Vandecasteele,Johan R. Boelaert +10 more
TL;DR: In this paper, the authors studied mitochondrial ultrastructure, mitochondrial respiratory chain enzyme activity, and mitochondrial DNA (mtDNA) in muscle, liver, and kidney samples obtained from a patient who developed optic neuropathy, encephalopathy, skeletal myopathy, lactic acidosis, and renal failure after prolonged use of linezolid.
Journal Article
Linezolid-induced inhibition of mitochondrial protein synthesis
Rudy Van Coster,Joél Smet,Sara Seneca,Andrew M. Lovering,Lindsey Van Haute,Ludo Vanopdenbosch,Jean-Jacques Martin,Chantal Ceuterick-de Groote,Stefaan J. Vandecasteele,Johan R. Boelaert,An S. De Vriese +10 more
TL;DR: These results provide direct evidence that linezolid inhibits mitochondrial protein synthesis with potentially severe clinical consequences and should be avoided if alternative treatment options are available.
Journal ArticleDOI
Desmin-related myopathy with Mallory body-like inclusions is caused by mutations of the selenoprotein N gene.
Ana Ferreiro,Chantal Ceuterick-de Groote,Jared J. Marks,Nathalie Goemans,Gudrun Schreiber,Folker Hanefeld,Michel Fardeau,Jean-Jacques Martin,Hans H. Goebel,Pascale Richard,Pascale Guicheney,Carsten G. Bönnemann +11 more
TL;DR: Findings substantiate the molecular heterogeneity of DRM, expand the morphological spectrum of SEPN‐RM, and implicate a necessary reassessment of the nosological boundaries in early‐onset myopathies.
Journal ArticleDOI
Cap disease caused by heterozygous deletion of the β-tropomyosin gene TPM2
Vilma-Lotta Lehtokari,Chantal Ceuterick-de Groote,Peter De Jonghe,M. Marttila,Nigel G. Laing,Katarina Pelin,Carina Wallgren-Pettersson +6 more
TL;DR: A deletion in the b-tropomyosin (TPM2) gene causing cap disease is reported in a 36-year-old male patient with congenital muscle weakness, myopathic facies and respiratory insufficiency, the first genetic cause identified for cap disease.